The impact of Alzheimer's disease medication on muscle relaxants.
作者信息
Russell W J
出版信息
Anaesth Intensive Care. 2009 Jan;37(1):134-5.
PMID:19160552
Abstract
摘要
相似文献
1
The impact of Alzheimer's disease medication on muscle relaxants.
Anaesth Intensive Care. 2009 Jan;37(1):134-5.
2
[Interaction of donepezil with rocuronium].
Duodecim. 2012;128(10):1031-2.
3
[Does rocuronium displace the position of suxamethonium?].
Masui. 2008 Jul;57(7):860-8.
4
Donepezil, Alzheimer's disease and suxamethonium.
Anaesthesia. 1997 Oct;52(10):1018.
5
[Sugammadex, a revolutionary new drug to reverse neuromuscular block].
Rev Esp Anestesiol Reanim. 2007 Apr;54(4):205-7.
6
Suxamethonium and donepezil: a cause of prolonged paralysis.
Anesthesiology. 2003 Feb;98(2):574-5. doi: 10.1097/00000542-200302000-00040.
7
Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital.
Anaesth Intensive Care. 2012 Sep;40(5):861-6. doi: 10.1177/0310057X1204000515.
8
[Cyclodextrin. A new concept for antagonizing muscle relaxants].
Anaesthesist. 2002 Nov;51(11):929-30. doi: 10.1007/s00101-002-0401-y.
9
Cosmetic anaphylaxis?
J Clin Anesth. 2009 Sep;21(6):461-3. doi: 10.1016/j.jclinane.2009.06.001.
10
[Sugammadex: a new approach to muscle relaxation and its reversal].
Ann Fr Anesth Reanim. 2009 Sep;28 Suppl 2:S39-40. doi: 10.1016/S0750-7658(09)72485-2.
Zotero 插件